Direct evidence for self-propagation of different amyloid-β fibril conformations

Thomas Spirig1, Oxana Ovchinnikova, Toni Vagt

  • 1Department of Biology, Institute of Molecular Biology and Biophysics, ETH Zurich, Zurich, Switzerland.

Abstract

Insights

Alzheimer's-associated amyloid-β (Aβ) peptides can form distinct fibril structures. This study shows that Aβ1-40 can propagate the conformation of a mutant strain, suggesting amyloid strains may contribute to Alzheimer's disease phenotypes.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Neuroscience

Background:

  • Amyloid fibrils composed of amyloid-beta (Aβ) peptides are implicated in Alzheimer's disease.
  • Distinct Aβ fibril morphologies exist, not solely determined by the peptide sequence.
  • Experimental evidence for stable propagation of distinct Aβ fibril conformations was lacking.

Purpose of the Study:

  • To investigate if the wild-type amyloid-beta 1-40 (Aβ1-40) peptide can assemble into fibrils mimicking the conformation of the mutant Aβ1-40 peptide with the Osaka mutation (E22Δ).

Main Methods:

  • Utilized highly pure, recombinant Aβ1-40 for in vitro fibril formation.
  • Employed preformed seeds of distinct conformations to initiate fibril growth.
  • Monitored fibril formation using thioflavin T fluorescence.
  • Characterized fibril structures via fluorescence spectroscopy and electron microscopy.

Main Results:

  • Successfully propagated the specific quaternary structure of Aβ1-40 E22Δ fibrils using wild-type Aβ1-40 over seven seeding cycles.
  • Despite a 10^7-fold dilution of E22Δ seeds, resulting Aβ1-40 fibrils retained the E22Δ conformation.
  • Fibrils seeded with E22Δ showed increased critical concentrations, indicating lower stability compared to homologous seeds, consistent with kinetic control.

Conclusions:

  • Demonstrates the capacity of Aβ peptide to form self-propagating amyloid strains.
  • The propagation of distinct Aβ fibril conformations supports their potential role in Alzheimer's disease pathogenesis.
  • Suggests that amyloid strain diversity may influence disease phenotypes.